Bolin Kevin 5
5 · QSAM Biosciences, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
Bolin Kevin
Director
Transactions
- Award
COMMON STOCK
2020-12-17$0.22/sh+695,854$153,088→ 1,209,490 total - Conversion
COMMON STOCK
2020-09-30$0.22/sh+113,636$25,000→ 513,636 total
Holdings
- 88,000
Options to buy common stock
Exercise: $0.50From: 2016-02-25Exp: 2026-02-25→ COMMON STOCK (88,000 underlying)
Footnotes (2)
- [F1]Shares acquired upon conversion of promissory note at a conversion price of $0.22 per share.
- [F2]Shares acquired upon conversion of accured salary at a conversion price of $0.22 per share.